Showing results (261-270 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|December 1, 2012
Meta-analysis of the safety, tolerability, and efficacy of lopinavir/ritonavir-containing antiretroviral therapy in HIV-1-infected womenA Hermes, K Squires, L Fredrick, et al.
HIV Clinical Trials|December 1, 2012
Comparison of functional status instruments in HIV-infected adults on effective antiretroviral therapyKristine M Erlandson, Amanda A Allshouse, Catherine M Jankowski, et al.
HIV Clinical Trials|August 22, 2014
Relationship between health-related quality of life measures and high HIV viral load in HIV-infected triple-class-experienced patientsRaffaella Bucciardini, Katherina Pugliese, Liliana Weimer, et al.
HIV Clinical Trials|July 10, 2013
Rilpivirine versus efavirenz in HIV-1-infected subjects receiving emtricitabine/tenofovir DF: pooled 96-week data from ECHO and THRIVE StudiesM R Nelson, R A Elion, C J Cohen, et al.
HIV Clinical Trials|December 1, 2014
Renal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: a focused safety analysis of ACTG PEARLS (A5175)F Touzard Romo, L M Smeaton, T B Campbell, et al.
HIV Clinical Trials|December 1, 2014
Effectiveness and safety of rilpivirine, a non-nucleoside reverse transcriptase inhibitor, in treatment-naive adults infected with HIV-1: a meta-analysisSheng-Li Li, Peng Xu, Lei Zhang, et al.
HIV Clinical Trials|February 23, 2016
Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN StudyEugénio Teófilo, Nuno Rocha-Pereira, Birger Kuhlmann, et al.
HIV Clinical Trials|December 17, 2013
Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202Philip M Grant, Camlin Tierney, Chakra Budhathoki, et al.
HIV Clinical Trials|December 17, 2013
Genetic predictors of cervical dysplasia in African American HIV-infected women: ACTG DACS 268Michelle S Cespedes, Sarah L Kerns, Robert S Holzman, et al.
HIV Clinical Trials|December 17, 2013
Pilot study of pioglitazone and exercise training effects on basal myocardial substrate metabolism and left ventricular function in HIV-positive individuals with metabolic complicationsW Todd Cade, Dominic N Reeds, E Turner Overton, et al.
Pageof 68